NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹20.31 | ₹20.85 | ₹18.43 | ₹-35.46 | ₹7.34 |
What is the latest Earnings Per Share (EPS) of NATH BIOGENES (INDIA) ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹20.31 |
| Mar2025 | ₹20.85 |
| Mar2024 | ₹18.43 |
| Mar2023 | ₹-35.46 |
| Mar2022 | ₹7.34 |
How is Earnings Per Share (EPS) of NATH BIOGENES (INDIA) Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹20.31 | -2.59 | |
| Mar2025 | ₹20.85 | 13.13 | |
| Mar2024 | ₹18.43 | Positive | |
| Mar2023 | ₹-35.46 | Negative | |
| Mar2022 | ₹7.34 | - | |
Compare Earnings Per Share (EPS) of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹284.7 Cr | -1.4% | -2% | -10.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,146.3 Cr | 13.4% | 2.5% | -33.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,327.2 Cr | 0.5% | 3.6% | 9.3% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,410.3 Cr | 2.7% | 6.5% | 24.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹923.8 Cr | 2% | -1.2% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹526.6 Cr | 0.8% | 9% | -0.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -1.4% |
-2% |
-10.1% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses